Vistagen Therapeutics Inc (NASDAQ: VTGN) kicked off on Friday, up 7.59% from the previous trading day, before settling in for the closing price of $3.95. Over the past 52 weeks, VTGN has traded in a range of $1.90-$5.14.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 35.63%. While this was happening, its average annual earnings per share was recorded -1.68%. With a float of $33.66 million, this company’s outstanding shares have now reached $38.89 million.
Vistagen Therapeutics Inc (VTGN) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Vistagen Therapeutics Inc is 19.03%, while institutional ownership is 44.96%.
Vistagen Therapeutics Inc (VTGN) Latest Financial update
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.46 earnings per share (EPS), higher than consensus estimate (set at -0.52) by 0.06. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.37 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -1.68% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 20.26% during the next five years compared to 35.63% growth over the previous five years of trading.
Vistagen Therapeutics Inc (NASDAQ: VTGN) Trading Performance Indicators
Take a look at Vistagen Therapeutics Inc’s (VTGN) current performance indicators. Last quarter, stock had a quick ratio of 5.79. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 239.80.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.58, a number that is poised to hit -0.37 in the next quarter and is forecasted to reach -1.75 in one year’s time.
Technical Analysis of Vistagen Therapeutics Inc (VTGN)
The latest stats from [Vistagen Therapeutics Inc, VTGN] show that its last 5-days average volume of 0.85 million was superior to 0.38 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 60.84%.
During the past 100 days, Vistagen Therapeutics Inc’s (VTGN) raw stochastic average was set at 64.26%, which indicates a significant increase from 50.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.47 in the past 14 days, which was higher than the 0.30 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.16, while its 200-day Moving Average is $3.03. Now, the first resistance to watch is $4.43. This is followed by the second major resistance level at $4.60. The third major resistance level sits at $4.84. If the price goes on to break the first support level at $4.02, it is likely to go to the next support level at $3.78. The third support level lies at $3.61 if the price breaches the second support level.
Vistagen Therapeutics Inc (NASDAQ: VTGN) Key Stats
The company with the Market Capitalisation of 167.86 million has total of 39,495K Shares Outstanding. Its annual sales at the moment are 490 K in contrast with the sum of -51,420 K annual income. Company’s last quarter sales were recorded 260 K and last quarter income was -19,420 K.
